Astera Labs (NASDAQ:ALAB) Stock Price Down 1.9% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) fell 1.9% on Friday . The stock traded as low as $277.30 and last traded at $284.97. 2,999,423 shares were traded during trading, a decline of 45% from the average session volume of 5,451,113 shares. The stock had previously closed at $290.52.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ALAB. Barclays increased their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Morgan Stanley upped their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Susquehanna boosted their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Rothschild & Co Redburn initiated coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $333.00.

Get Our Latest Report on Astera Labs

Astera Labs Trading Down 1.9%

The company’s fifty day moving average is $354.34 and its 200 day moving average is $244.64. The company has a market capitalization of $49.44 billion, a P/E ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the prior year, the firm posted $0.44 EPS. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs in the 4th quarter worth approximately $18,708,000. Swedbank AB boosted its stake in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in shares of Astera Labs during the fourth quarter valued at approximately $499,000. Revere Asset Management Inc bought a new position in shares of Astera Labs in the fourth quarter worth approximately $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new position in shares of Astera Labs in the fourth quarter worth approximately $10,299,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.